Virtual Surgery of the Upper Airways

NCT ID: NCT04829201

Last Updated: 2023-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-20

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obstructive sleep apnea (OSA) is a sleep related breathing disorder caused by repetitive collapses of the upper airways resulting in impaired breathing, oxygen desaturation and sleep disturbances. OSA has a massive impact on global health contributing directly to cardiovascular diseases, insulin resistance, metabolic syndrome and daytime fatigue and is repeatedly associated with an increase in motor vehicle accidents.

The mainstay of treatment is still the use of positive airway pressure or surgery of the upper airways, but the success rate is persistently low. Surgery may be of help, but there is a lack of patient-specific options in both diagnostics and treatment.

Mathematical and computational modeling is expected to provide significant insight into the airway function and onset of OSA.

This study is part of a project that will rely on biomedical engineering to obtain the required insight to produce software tools for computer-aided diagnostics and treatment of OSA.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is the clinical part of a project that contains 4 work packages (WP 1-4). The clinical study (work WP 1) will ensure the inclusion of up to 30 patients with verified sleep apnea that will be in need of either structural nasal surgery, pharyngeal surgery or orthognathic surgery. Studies of nasal airflow and pressure as well as a detailed ConeBeam CT scans of the upper airways will be performed before and after surgery.

WP 2, 3 and 4 deals with the mathematical modeling, structural mechanic modeling and the patient-specific airflow modeling.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea, Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obstructive sleep apnea (OSA)

OSA patients who are eligible for either functional septorhinoplasty or oropharyngeal/orthognathic surgery

functional septorhinoplasty or oropharyngeal/orthognathic surgery

Intervention Type PROCEDURE

obtain pre- and postoperative data in order to describe the specific changes in airflow and upper soft tissue behavior that causes sleep apnea

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

functional septorhinoplasty or oropharyngeal/orthognathic surgery

obtain pre- and postoperative data in order to describe the specific changes in airflow and upper soft tissue behavior that causes sleep apnea

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Obstructive sleep apnea
* need either functional septorhinoplasty or oropharyngeal/orthognathic surgery in order to establish adequate airway patency
* have undergone sleep registration using polysomnography and ultrawideband radar
* on the subsequent clinical evaluation presenting either 1) intranasal obstruction, due to malalignment of the nasal septal cartilage or the nasal outer framework; and/or 2) oropharyngeal obstruction or retrognathia.

Exclusion Criteria

* previous nasal or oropharyngeal surgery
* previous use of nasal decongestant or nasal topical steroids over the last 3 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SINTEF Health Research

OTHER

Sponsor Role collaborator

St. Olavs Hospital

OTHER

Sponsor Role collaborator

Norwegian University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bjørn H Skallerud, phd prof

Role: STUDY_DIRECTOR

NTNU, Fac IV, Dept of Structural Engineering

Ståle Nordgård, phd prof

Role: PRINCIPAL_INVESTIGATOR

NTNU, Fac MH, Dept of Neuromedicine and Movement Science

Bernhard Müller, phd prof

Role: PRINCIPAL_INVESTIGATOR

NTNU, Fac IV, Dept of Energy and Process Engineering

Sverre G Johnsen, phd

Role: PRINCIPAL_INVESTIGATOR

SINTEF Health Research

Ståle Nordgård, phd prof

Role: STUDY_DIRECTOR

St Olavs Hospital, Clinic Ear Nose and Throat

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St Olavs Hospital

Trondheim, Trøndelag, Norway

Site Status RECRUITING

Aleris Solsiden

Trondheim, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mads HS Moxness, md phd

Role: CONTACT

+47 99035515

Ståle Nordgård, phd prof

Role: CONTACT

0047 72880232

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mads HS Moxness, md phd

Role: primary

Mads Henrik Strand Moxness, md phd

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RCN303218

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Personalised Treatment for OSA
NCT06915077 ENROLLING_BY_INVITATION